Skip Navigation


Rheumatology Advance Access originally published online on March 29, 2006
Rheumatology 2006 45(10):1201-1209; doi:10.1093/rheumatology/kel078
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary data
Right arrow All Versions of this Article:
45/10/1201    most recent
kel078v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Amos, N.
Right arrow Articles by Bondeson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amos, N.
Right arrow Articles by Bondeson, J.
Related Collections
Right arrow Osteoarthritis and Cartilage
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor I{kappa}B{alpha} reveals that most, but not all, inflammatory and destructive mediators are NF{kappa}B dependent

N. Amos, S. Lauder1, A. Evans1, M. Feldmann2 and J. Bondeson1

Department of Rheumatology, University Hospital of Wales, 1Department of Rheumatology, Cardiff University, Heath Park, Cardiff CF14 4XN and 2Kennedy Institute of Rheumatology Division, Imperial College School of Medicine, 1 Aspenlea Road, Hammersmith, London W6 8LH, UK.

Correspondence to: J. Bondeson, Department of Rheumatology, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. E-mail: BondesonJ{at}cf.ac.uk


   Abstract

Objectives. Despite recent major advances in the understanding of the pathogenesis of rheumatoid arthritis, with tumour necrosis factor-alpha (TNF{alpha}) established as a major therapeutic target, comparatively little is known about the mediators involved in the destructive and inflammatory pathways in osteoarthritis (OA). Recently, it has become appreciated that an inflammatory synovitis contributes not only to the signs and symptoms of osteoarthritis, but also to disease progression. Here, we use high-efficiency adenoviral gene transfer to investigate the role of the transcription factor nuclear factor-{kappa}B (NF{kappa}B) in regulating inflammatory and destructive mediators in the late stage OA synovium.

Methods. Infection with reporter adenoviruses transferring the β-galactosidase or green fluorescent protein genes verified that OA synovial cells could be infected (>95%). Adenovirus transferring the inhibitory subunit I{kappa}B{alpha} inhibited NF{kappa}B. The production of a whole array of pro- and anti-inflammatory cytokines and mediators, and several matrix metalloproteinases and their main inhibitor, was measured by enzyme-linked immunosorbent assay.

Results. The spontaneous production of macrophage-produced pro-inflammatory cytokines varied: TNF{alpha} was modestly inhibited by I{kappa}B{alpha} overexpression, but interleukin (IL)-1 was unaffected. Both IL-6 and IL-8 were potently inhibited, as were granulocyte–macrophage colony stimulating factor and oncostatin M. Anti-inflammatory mediators like IL-10, the IL-1 receptor antagonist and the p55 soluble TNF receptor were unaffected. Matrix metalloproteinases 1, 3, 9 and 13 were potently inhibited by I{kappa}B{alpha} overexpression, but not their main inhibitor tissue inhibitor of metalloproteinase-1.

Conclusions. The OA synovium is a highly inflammatory environment, with spontaneous production of many cytokines and matrix metalloproteinases. Inhibition of NF{kappa}B may have a beneficial effect on the balance between pro-inflammatory cytokines and anti-inflammatory mediators, and between destructive metalloproteinases and their main inhibitor.

KEY WORDS: Adenovirus, Fibroblast, Interleukin-1, Macrophage, Matrix metalloproteinase, NF-kappa-B, Osteoarthritis, Synovium, Tumour necrosis factor

Submitted 1 September 2005; revised version accepted 10 February 2006.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
S. N. Lauder, S. M. Carty, C. E. Carpenter, R. J. Hill, F. Talamas, J. Bondeson, P. Brennan, and A. S. Williams
Interleukin-1{beta} induced activation of nuclear factor-{kappa}b can be inhibited by novel pharmacological agents in osteoarthritis
Rheumatology, May 1, 2007; 46(5): 752 - 758.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.